Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
microscopy. Experience in assay development, quantitative image analysis, biomaterial-cell interactions, nanoparticle uptake and intracellular trafficking, cancer biology, stem or progenitor cells, osteogenic
-
. PhD Candidate in advanced immune competent liver models Apply for this job See advertisement About the position The Hybrid Technology Hub CoE (https://www.med.uio.no/hth/english/ ) is inviting
-
, or MD/PhD. in Immunology, Hematology, Stem Cell Biology, Molecular Biology, Genetics, or a related field. Demonstrated research productivity and the ability to conduct independent scientific research
-
hold a PhD/DPhil or equivalent a relevant discipline along with: Strong hands‑on experience of stem cell-derived models Demonstrated expertise in adipose tissue biology and adipocyte differentiation
-
specific clinical presentations. You will use cutting-edge technologies, including functional studies on neuronal and muscle stem cells and human organoids. RNA sequencing and other omics technologies will
-
at the rank of Assistant or Associate Professor, with expertise in the field of Cell and Molecular Neuroscience. We are particularly interested in candidates whose research incorporates induced pluripotent stem
-
Lunenfeld-Tanenbaum Research Institute | Central Toronto Roselawn, Ontario | Canada | about 14 hours ago
developmental origins of health and disease. We welcome applications exploring the molecular, cellular, and genetic mechanisms that drive early development and stem cell dynamics. Research approaches and
-
Engineering and Cell Culture Laboratory (TECCL) as well as the Soft Matter (SoMa) Characterization Facility, overseeing budget, and serving as PI/Co-PI on research grants and contracts. This position will make
-
and translational cardiometabolic research. The laboratory is focusing on regenerative cardiology using stem cell therapy to investigate cardio-immunology regeneration. We work with pluripotent stem
-
that clomipramine rescues the altered SMPD1 (acid sphingomyelinase) phenotype in SMA cellular models, including human induced pluripotent stem cell (iPSC)-derived motor neurons (Brokate et al., 2025). Since SMPD1